Wu JX - Search Results

1

Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8⁺-T cell immunity.

Liu F, Zhou Q, Jiang HF, Zhang TT, Miao C, Xu XH, Wu JX, Yin SL, Xu SJ, Peng JY, Gao PP, Cao X, Pan F, He X, Chen XQ. Liu F, et al. Among authors: wu jx. J Exp Clin Cancer Res. 2023 May 10;42(1):118. doi: 10.1186/s13046-023-02686-1. J Exp Clin Cancer Res. 2023. PMID: 37161450 Free PMC article.

2

A molecularly distinct cell type in the midbrain regulates intermale aggression behaviors in mice.

Li C, Miao C, Ge Y, Wu J, Gao P, Yin S, Zhang P, Yang H, Tian B, Chen W, Chen XQ. Li C, et al. Theranostics. 2025 Jan 1;15(2):707-725. doi: 10.7150/thno.101658. eCollection 2025. Theranostics. 2025. PMID: 39744695 Free PMC article.

3

CD73 inhibitor AB680 suppresses glioblastoma in mice by inhibiting purine metabolism and promoting P2RY12⁺ microglia transformation.

Gao PP, Jiang HF, Du YW, Shu Y, Wan YW, Yin EZ, Wu JX, Liang XX, Wang SD, Ding ZH, Xu XH, An Q, Miao C, He XM, Li MF, Liu F, Chen XQ. Gao PP, et al. Among authors: wu jx. Acta Pharmacol Sin. 2025 Nov;46(11):3053-3070. doi: 10.1038/s41401-025-01585-9. Epub 2025 Jun 11. Acta Pharmacol Sin. 2025. PMID: 40500344

4

Identification and targeting oxidative phosphorylation/glycolysis to overcome anti-CSF-1R therapy resistance in glioblastoma.

Miao C, Ding Z, Wu J, An Q, Shu Y, Jiang H, Gao P, Chen R, Chen XQ. Miao C, et al. Cell Death Dis. 2025 Dec 10;17(1):84. doi: 10.1038/s41419-025-08288-3. Cell Death Dis. 2025. PMID: 41365876 Free PMC article.

5

Investigating potential drug targets for the treatment of glioblastoma: a Mendelian randomization study.

Zhang H, Wang Z, Qiao X, Wu J, Cheng C. Zhang H, et al. BMC Cancer. 2025 Apr 10;25(1):654. doi: 10.1186/s12885-025-13979-3. BMC Cancer. 2025. PMID: 40211130 Free PMC article.

6

Unveiling the therapeutic potential of IHMT-337 in glioma treatment: targeting the EZH2-SLC12A5 axis.

Zhang H, Wang Z, Qiao X, Peng N, Wu J, Chen Y, Cheng C. Zhang H, et al. Mol Med. 2024 Jun 17;30(1):91. doi: 10.1186/s10020-024-00857-0. Mol Med. 2024. PMID: 38886655 Free PMC article.

7

The relationship between microscopic margin positivity and disease recurrence in differentiated thyroid cancer.

Seo YJ, Ranjbar S, Ngo S, Moleta C, Sajed DP, Hughes EG, Shu ML, Hu MY, Livhits MJ, Yeh MW, Wu JX. Seo YJ, et al. Among authors: wu jx. Surgery. 2026 May 12;196:110318. doi: 10.1016/j.surg.2026.110318. Online ahead of print. Surgery. 2026. PMID: 42224966

8

Anticancer Effects of Cepharanthine: an Updated Minireview.

Yang PY, Wu JX, Chen YH, Yang SF, Chu YT, Hsiao YH. Yang PY, et al. Among authors: wu jx. J Cancer. 2026 Apr 8;17(5):925-936. doi: 10.7150/jca.118647. eCollection 2026. J Cancer. 2026. PMID: 42179796 Free PMC article. Review.

9

EHR-Based Screening for Primary Aldosteronism in a Large Academic System.

Ngo S, Chao JC, Sahadeo J, Konstantopoulos AD, Hughes EG, Larios KN, Wu JX, Yeh MW, Livhits MJ. Ngo S, et al. Among authors: wu jx. Endocr Pract. 2026 May 21:S1530-891X(26)01001-3. doi: 10.1016/j.eprac.2026.05.022. Online ahead of print. Endocr Pract. 2026. PMID: 42173282 Free article.

10

Substrate recognition and allosteric inhibition of human betaine/GABA transporter 1.

Zhou J, Liu J, Jin Y, Wang Q, Yu H, Wu JX. Zhou J, et al. Among authors: wu jx. Nat Commun. 2026 May 19. doi: 10.1038/s41467-026-72924-5. Online ahead of print. Nat Commun. 2026. PMID: 42156742 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

725 results

Search Page

Filters